The oil and gas industry is in the midst of enormous change. Global demand is rising, energy transition pressures are intensifying and the complexity of balancing investment in tr ...

Against this backdrop, Hexagon’s Asset Lifecycle Intelligence division is taking an unconventional step with a bold, new ...

Cardinal Health, Inc. CAH reported first-quarter fiscal 2026 adjusted earnings per share (EPS) of $2.55, which beat the Zacks Consensus Estimate of $2.21 by 15.4%. The bottom line also improved 35.6% ...

Perplexity’s agreement with Getty appears to legitimize some of the startup’s previous use of Getty’s stock photos.

Discover Harrow Inc.'s growth strategy, bullish long-term prospects, and Q3 earnings outlook in ophthalmology. Click for more ...

Increased 4.5% to $8.41 at the end of Q3 2025, reflecting gains across agency mortgage-backed securities. Economic return -- ...

In this week’s edition of InnovationRx, we look at the battle for Metsera, the departure of FDA’s top drug regulator, Kimberly-Clark’s $40 billion Kenvue deal, and more.

Crinetics Pharmaceuticals' stock has surged after FDA approval of Palsonify for acromegaly. Click here to read the latest ...

Investing in high-quality stocks with generous dividend payouts can help you gradually build substantial wealth.

The tech rivalry with the U.S. has made China take an unusual step: It is accelerating the pace at which startups go public ...